Herbal Products for IBS; Liver Transplant, Diabetes, and Cancer; IBD Work Impairment

A case-control study revealed which patients were more likely to use herbal products for irritable bowel syndrome. (BMC Gastroenterology)

Diabetes following a liver transplant was linked to cancer risk, a study from Italy found. (Annals of Hepatology)

A culturally tailored patient navigation program helped to both increase colorectal screening and eliminate gender gaps in screening among Hispanic patients. (Cancer)

Second Genome said it plans to continue the development of SG-5-00455 -- a PAI-1/2-targeting drug candidate for inflammatory bowel disease (IBD) -- and will unveil preclinical data at the European Crohn's and Colitis Organization's virtual congress next week.

A Connecticut woman with autoimmune hepatitis and primary sclerosing cholangitis finally received a new liver from a living donor. (WTNH.com)

Low-dose aspirin was associated with lower risks of colorectal and gastric cancer, but with greater risks for gastrointestinal bleeding, a Chinese study found. (BMJ Open)

Taking biologics or starting tofacitinib (Xeljanz) led to a decline in work impairment among patients with IBD. (Inflammatory Bowel Diseases)

Metacrine got a go-ahead from FDA to proceed to phase II trials for MET642, its therapeutic candidate to treat ulcerative colitis, though the company will undergo a restructuring to make this happen.

Introduction of HPV vaccination in the U.S. was associated with a lower incidence of squamous cell carcinoma of the anus among people of vaccine-eligible age, a cross-sectional study suggested. (JAMA Oncology)

Comment